Company page

Arrivent Biopharma, Inc.

Arrivent Biopharma, Inc. is a public company traded under the ticker AVBP in the American market. The company has a market capitalization of approximately $1.55 billion. Arrivent focuses on developing innovative biopharmaceutical solutions to address unmet medical needs.

AVBP:NASDAQUpdated September 11, 2026
Arrivent Biopharma, Inc. logo
Ticker
AVBP:NASDAQ
Asset type
Stock
Market cap
$1.43B
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
NASDAQ
Currency
USD